-
Fearless talent: Five young players to watch at the T20 World Cup
-
India favourites as T20 World Cup to begin after chaotic build-up
-
Voter swings raise midterm alarm bells for Trump's Republicans
-
Australia dodges call for arrest of visiting Israel president
-
Countries using internet blackouts to boost censorship: Proton
-
Top US news anchor pleads with kidnappers for mom's life
-
Thailand's pilot PM on course to keep top job
-
The coming end of ISS, symbol of an era of global cooperation
-
New crew set to launch for ISS after medical evacuation
-
Family affair: Thailand waning dynasty still election kingmaker
-
Japan's first woman PM tipped for thumping election win
-
Stocks in retreat as traders reconsider tech investment
-
LA officials call for Olympic chief to resign over Epstein file emails
-
Ukraine, Russia, US to start second day of war talks
-
Fiji football legend returns home to captain first pro club
-
Trump attacks US electoral system with call to 'nationalize' voting
-
Barry Manilow cancels Las Vegas shows but 'doing great' post-surgery
-
US households become increasingly strained in diverging economy
-
Four dead men: the cold case that engulfed a Colombian cycling star
-
Super Bowl stars stake claims for Olympic flag football
-
On a roll, Brazilian cinema seizes its moment
-
Rising euro, falling inflation in focus at ECB meeting
-
AI to track icebergs adrift at sea in boon for science
-
Indigenous Brazilians protest Amazon river dredging for grain exports
-
Google's annual revenue tops $400 bn for first time, AI investments rise
-
Last US-Russia nuclear treaty ends in 'grave moment' for world
-
Man City brush aside Newcastle to reach League Cup final
-
Guardiola wants permission for Guehi to play in League Cup final
-
Boxer Khelif reveals 'hormone treatments' before Paris Olympics
-
'Bad Boy,' 'Little Pablo' and Mordisco: the men on a US-Colombia hitlist
-
BHP damages trial over Brazil mine disaster to open in 2027
-
Dallas deals Davis to Wizards in blockbuster NBA trade: report
-
Iran-US talks back on, as Trump warns supreme leader
-
Lens cruise into French Cup quarters, Endrick sends Lyon through
-
No.1 Scheffler excited for Koepka return from LIV Golf
-
Curling quietly kicks off sports programme at 2026 Winter Olympics
-
Undav pokes Stuttgart past Kiel into German Cup semis
-
Germany goalkeeper Ter Stegen to undergo surgery
-
Bezos-led Washington Post announces 'painful' job cuts
-
Iran says US talks are on, as Trump warns supreme leader
-
Gaza health officials say strikes kill 24 after Israel says officer wounded
-
Empress's crown dropped in Louvre heist to be fully restored: museum
-
UK PM says Mandelson 'lied' about Epstein relations
-
Shai to miss NBA All-Star Game with abdominal strain
-
Trump suggests 'softer touch' needed on immigration
-
From 'flop' to Super Bowl favorite: Sam Darnold's second act
-
Man sentenced to life in prison for plotting to kill Trump in 2024
-
Native Americans on high alert over Minneapolis crackdown
-
Dallas deals Davis to Wizards in blockbuster NBA deal: report
-
Russia 'no longer bound' by nuclear arms limits as treaty with US ends
US pharmacy chains announce abortion pill rollout
America's two biggest pharmacy chains said Friday they will begin dispensing prescription abortion pills in a limited number of states where it's legal.
The move greatly broadens availability of the drug mifepristone, even as a legal case over whether it was properly approved two decades ago now rests before the Supreme Court.
Walgreens "expects to begin dispensing within a week" in New York, Pennsylvania, Massachusetts, California, and Illinois, the company said on its website.
"But in the interests of pharmacist and patient safety, we will not disclose the number of sites per state nor identify the pharmacies that are dispensing," it added.
A CVS spokesperson told AFP: "We'll begin filling prescriptions for the medication in Massachusetts and Rhode Island in the weeks ahead and will expand to additional states, where allowed by law, on a rolling basis."
The Food and Drug Administration (FDA) authorized pharmacies to carry mifepristone in January 2023, with Friday's announcements the results of a long certification process.
Mifepristone works to block a pregnancy, while a second drug, misoprostol, provokes bleeding to empty the uterus and was already widely available in pharmacies.
The news was hailed by President Joe Biden, who has made protecting reproductive rights a key part of his re-election campaign against the likely Republican candidate Donald Trump.
Trump tipped the balance of the Supreme Court during his own presidency and paved the way for reversal of the national right to abortion.
"With major retail pharmacy chains newly certified to dispense medication abortion, many women will soon have the option to pick up their prescription at a local, certified pharmacy -- just as they would for any other medication," Biden said in a statement.
"The stakes could not be higher for women across America. In the face of relentless attacks on reproductive freedom by Republican elected officials, Vice President Harris and I will continue to fight to ensure that women can get the health care they need."
The US Supreme Court overturned the nationwide right to abortion in 2022, allowing each state to pass its own laws governing the procedure.
Twenty-one states have since banned or moved to restrict abortions to limits tighter than before Roe v Wade, the previous case that upheld the constitutional right to terminate a pregnancy.
Abortion pills remain illegal in states where the procedure is prohibited. But women who decide to travel to a state where abortion is legal may now find a pharmacy much closer than an abortion clinic, reducing their travel.
The Supreme Court will hear arguments March 26 in a case brought by anti-abortion groups to restrict access to mifepristone, first approved in the year 2000 and used by more than 5.6 million Americans since.
N.Shalabi--SF-PST